IE38554B1 - Fluoro-substituted thiaxanthene derivatives - Google Patents

Fluoro-substituted thiaxanthene derivatives

Info

Publication number
IE38554B1
IE38554B1 IE2161/73A IE216173A IE38554B1 IE 38554 B1 IE38554 B1 IE 38554B1 IE 2161/73 A IE2161/73 A IE 2161/73A IE 216173 A IE216173 A IE 216173A IE 38554 B1 IE38554 B1 IE 38554B1
Authority
IE
Ireland
Prior art keywords
compounds
nme
reacting
fluorothiaxanth
ylidene
Prior art date
Application number
IE2161/73A
Other versions
IE38554L (en
Original Assignee
Kefalas As
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kefalas As filed Critical Kefalas As
Publication of IE38554L publication Critical patent/IE38554L/en
Publication of IE38554B1 publication Critical patent/IE38554B1/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D295/00Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms
    • C07D295/04Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms
    • C07D295/08Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms
    • C07D295/084Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings
    • C07D295/088Heterocyclic compounds containing polymethylene-imine rings with at least five ring members, 3-azabicyclo [3.2.2] nonane, piperazine, morpholine or thiomorpholine rings, having only hydrogen atoms directly attached to the ring carbon atoms with substituted hydrocarbon radicals attached to ring nitrogen atoms substituted by singly bound oxygen or sulfur atoms with the ring nitrogen atoms and the oxygen or sulfur atoms attached to the same carbon chain, which is not interrupted by carbocyclic rings to an acyclic saturated chain
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P25/00Drugs for disorders of the nervous system
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07CACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C323/00Thiols, sulfides, hydropolysulfides or polysulfides substituted by halogen, oxygen or nitrogen atoms, or by sulfur atoms not being part of thio groups
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D337/00Heterocyclic compounds containing rings of more than six members having one sulfur atom as the only ring hetero atom
    • C07D337/02Seven-membered rings
    • C07D337/06Seven-membered rings condensed with carbocyclic rings or ring systems
    • C07D337/10Seven-membered rings condensed with carbocyclic rings or ring systems condensed with two six-membered rings
    • C07D337/14[b,f]-condensed

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Biomedical Technology (AREA)
  • Neurology (AREA)
  • Neurosurgery (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)

Abstract

1453828 Thiaxanthene derivatives KEFALAS AS 28 Nov 1973 [8 Dec 1972] 56910/72 Heading C2C The invention comprises compounds of formula and their addition salts with pharmaceutically acceptable acids, wherein X is Cl, CF 3 or SO 2 NMe 2 ; Z is >CHCH 2 - or >C : CH-; and Y is >NH, >NMe, >NCH 2 CH 2 OH or > CHCH 2 CH 2 OH, and the esters of these alcohols with C 1-17 alkanoic acids. In examples, these compounds are prepared by (1) reducing the unsaturated to the saturated compounds; (2) reacting the analogues having the side-chain terminated by: CH 2 , Cl or NMe 2 with (3) forming the compound where Y is by reacting that where Y is >NH with ethylene oxide; (4) esterifying the alcohols; (5) reacting a 9-Li derivative of a 9-unsubstituted 3-fluorothioxanthene (which is derived from the corresponding thiaxanthone) with (6) splitting the corresponding methyl ether of the desired alcohol. Analogues of the compounds (I) having a 5- or 6-Cl or CF 3 substituent instead of 6-F are also disclosed. Starting materials and intermediates otherwise described are 1-(3-chloropropyl)-4-(2-methoxyethyl)piperazine, and those of formulµ R<SP>2</SP>(-OH)CH 2 CH : CH 2 and R<SP>2</SP> : O, where R is 3-FC 6 H 4 , R<SP>1</SP> is 2-chloro(or trifluoromethyl)-6- fluorothiaxanth-9-ylidene, and R<SP>2</SP> is 2-dimethylsulphamoyl-6-fluorothiaxanth-9-ylidene. Therapeutic compositions having neuroleptic activity comprise compounds of the above formula, and may be administered orally or parenterally. [GB1453828A]
IE2161/73A 1972-12-08 1973-11-29 Fluoro-substituted thiaxanthene derivatives IE38554B1 (en)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
GB5691072A GB1453828A (en) 1972-12-08 1972-12-08 Fluoro-substituted thiaxanthene derivatives

Publications (2)

Publication Number Publication Date
IE38554L IE38554L (en) 1974-06-08
IE38554B1 true IE38554B1 (en) 1978-04-12

Family

ID=10477876

Family Applications (1)

Application Number Title Priority Date Filing Date
IE2161/73A IE38554B1 (en) 1972-12-08 1973-11-29 Fluoro-substituted thiaxanthene derivatives

Country Status (19)

Country Link
JP (1) JPS594436B2 (en)
AR (2) AR202805A1 (en)
AT (1) AT332395B (en)
BE (1) BE808347A (en)
CH (2) CH590272A5 (en)
CS (1) CS176259B2 (en)
DE (1) DE2359359C3 (en)
DK (1) DK145576C (en)
ES (2) ES421098A1 (en)
FI (1) FI57410C (en)
FR (1) FR2209573B1 (en)
GB (1) GB1453828A (en)
HU (1) HU167778B (en)
IE (1) IE38554B1 (en)
NL (1) NL7316035A (en)
NO (1) NO138806C (en)
PL (1) PL95266B1 (en)
SE (1) SE400287B (en)
ZA (1) ZA738990B (en)

Families Citing this family (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NZ189108A (en) * 1977-12-29 1982-02-23 Kefalas As 2-methylthio-6-fluoro-9-(1-methyl-4-piperidylidene)-thioxanthene and pharmaceutical compositions intermediate 2-methylthio-6-fluoro-9-(1-methyl-4-piperidyl)-thioxanthen-9-ol
US5173489A (en) * 1986-04-10 1992-12-22 The Dupont Merck Pharmaceutical Co. α,α-disubstituted aromatics and heteroaromatics as cognition enhancers
GB8628903D0 (en) * 1986-12-03 1987-01-07 Lunbeck A S H Neuroleptic compounds
US6395752B1 (en) * 1999-03-04 2002-05-28 Pharmaquest Limited Method of treating depression using 1-threo-methylphenidate
US6127385A (en) * 1999-03-04 2000-10-03 Pharmaquest Limited Method of treating depression using l-threo-methylphenidate
WO2008080398A1 (en) * 2007-01-05 2008-07-10 Bkg Pharma Aps Anti - infective agents such as phenothiazine and thioxanthene derivates to treat infectious diseases

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
BE585338A (en) * 1958-12-04
FR1463787A (en) * 1963-10-14 1966-07-22 Pfizer & Co C Aminoalkyl-trisubstituted phosphonium compounds, derivatives of such compounds, and processes for their preparation

Also Published As

Publication number Publication date
AT332395B (en) 1976-09-27
FI57410C (en) 1980-08-11
ZA738990B (en) 1974-11-27
AR202672A1 (en) 1975-06-30
ES421098A1 (en) 1976-08-01
FR2209573B1 (en) 1977-12-09
DE2359359A1 (en) 1974-06-27
NO138806C (en) 1978-11-15
ES444294A1 (en) 1977-10-01
PL95266B1 (en) 1977-10-31
DE2359359C3 (en) 1978-11-02
AR202805A1 (en) 1975-07-24
SE400287B (en) 1978-03-20
FI57410B (en) 1980-04-30
AU6296673A (en) 1975-05-29
HU167778B (en) 1975-12-25
JPS4994691A (en) 1974-09-09
FR2209573A1 (en) 1974-07-05
DK145576C (en) 1983-06-13
BE808347A (en) 1974-03-29
IE38554L (en) 1974-06-08
ATA1000373A (en) 1976-01-15
CH590272A5 (en) 1977-07-29
GB1453828A (en) 1976-10-27
CS176259B2 (en) 1977-06-30
NO138806B (en) 1978-08-07
DK145576B (en) 1982-12-13
DE2359359B2 (en) 1978-02-16
JPS594436B2 (en) 1984-01-30
CH592085A5 (en) 1977-10-14
NL7316035A (en) 1974-06-11

Similar Documents

Publication Publication Date Title
KR870007119A (en) Quinone derivatives, their preparation and uses
IE36797L (en) 1,5-benzodiazepin-2-one derivatives.
IE34511B1 (en) Heterocyclic ethers of-1-substituted-4-hydroxyalkyl piperazines and process for preparing them
IE38554B1 (en) Fluoro-substituted thiaxanthene derivatives
CH633250A5 (en) METHOD FOR PRODUCING NEW POLYPRENYL DERIVATIVES.
SE7608037L (en) 2-SUBSTITUTED OXAZOLOPYRIDINES
GB1289240A (en)
GB1515060A (en) 3-hydroxymethylene-6,7-dimethoxy-2-methyl-4-oxo-1,2,3,4-tetrahydro-1-quinoline carboxylic acid esters
GB1495665A (en) Pyrimidines
GB1397731A (en) Monothiachromone-2-carboxylic acids
ES8105254A1 (en) Alkanoic acid derivatives
SE8204393D0 (en) NEW BICYCLIC COMPOUNDS AND A PROCESS FOR THE PREPARATION THEREOF
IE36865B1 (en) Imidazolines and process for the preparation thereof
GB1298432A (en) Phenyl-azolyl-fatty acid derivatives, process for their production and their use as medicines
IE43028L (en) PYRIMIDO [1,2-a] QUINOLINE DERIVATIVES
RU95107150A (en) Derivatives of pyridobenzoxadiazine carboxylic acid mixture of their isomers or individual isomers, their pharmaceutically acceptable hydrates and salts, intermediate products for their production, and pharmaceutical composition having antibactericidal activity on their base
GB1377306A (en) Esters of 2-quinoxalinecarboxylic acid di n-oxide
GB1510423A (en) Oxadiazole derivatives and their salts process for their preparation and compositions incorporating them
IL39743A (en) 1-isopropyl-4-(4&#39;-fluorophenyl)-7-methyl-2(1h)-quinazolinone,processes for the production thereof and pharmaceutical compositions comprising this compound
IE33364L (en) Morpholino- and thiomorpholino-pyrimidines.
GB1504683A (en) Pharmaceutical compositions containing substituted pyrimido-quinoline derivatives
ES278796A1 (en) New uracil derivatives and process for their production
YU46441B (en) PROCESS FOR PREPARATION OF 8 {- / 4- (2-PYRIMIDINYL) -1-PIPERAZINYL / BUTYL} -8-AZA-1-SPIRO / 4,5 / -DECAN-7,9-DIONE
JPH01213265A (en) 3-substituted pyridine-n-oxide and fungicide containing the same
GB1425808A (en) Pharmaceutically useful prostanoic acid derivatives